NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Utah Governor Cox and BioUtah Recognize Co-Diagnostics' Saudi Arabia Joint Venture
TL;DR
Co-Diagnostics gains strategic advantage by establishing CoMira Diagnostics joint venture in Saudi Arabia, expanding its patented PCR platform across Middle East and North Africa markets.
Co-Diagnostics forms CoMira Diagnostics through a definitive joint venture agreement with Arabian Eagle to localize manufacturing and distribution of its molecular diagnostic tests in Saudi Arabia.
Co-Diagnostics' expansion into Middle Eastern markets through CoMira Diagnostics will improve global healthcare access by providing advanced diagnostic tools to more patients worldwide.
A Utah-born diagnostics company recognized by Governor Cox is now competing globally through a Saudi joint venture that localizes PCR technology across the Middle East.
Found this article helpful?
Share it with your network and spread the knowledge!
Co-Diagnostics' formation of CoMira Diagnostics, a joint venture in the Kingdom of Saudi Arabia to localize their Co-Dx PCR platform across the Middle East and North Africa region.
Utah Governor Spencer Cox and Kelvyn Cullimore, President and CEO of BioUtah, are both recognizing the company for this international expansion.
It demonstrates the strength of Utah's life sciences sector and shows that Utah-born companies can compete on the world stage, representing one of the fastest-growing life sciences communities in the United States.
Co-Diagnostics is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies for detecting and analyzing nucleic acid molecules (DNA or RNA).
BioUtah is an independent trade association serving Utah's life sciences industry, and Co-Diagnostics is one of their Elite members representing the state's growing medical technology sector.
The joint venture will localize Co-Diagnostics' PCR platform across the Middle East and North Africa region, starting with the Kingdom of Saudi Arabia.
The recognition was announced on November 12, 2025, following Co-Diagnostics' joint venture announcement on October 27, 2025.
The Co-Dx PCR platform, which includes at-home and point-of-care diagnostic tests (subject to regulatory review and not currently for sale), will be localized across the Middle East.
Governor Cox stated that Co-Diagnostics' expansion reflects the strength of Utah's life sciences and the grit of Utah entrepreneurs, building tools that help patients worldwide.
Curated from Reportable
